


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.16%
+5.91%
-2.84%
+6.61%
CRL
Charles River Labora
$178.49
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
CRL Price Performance
$213.22 (-16.29%)
$187.12 (-4.61%)
$167.03 (+6.86%)
$174.98 (+2.01%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Revenue increase YoY
Loss widens YoY
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CRL Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRL Street Sentiment is bullish and have positive views on the near-term outlook
CRL has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 24, 2026
Reiterate
Buy
Mizuho
Dec 18, 2025
Reiterate
Neutral
Mizuho
Dec 16, 2025
Reiterate
Neutral
JP Morgan
Dec 16, 2025
Reiterate
Overweight
Barclays
Nov 11, 2025
Reiterate
Buy
TD Cowen
IQV
IQVIA Holdings
178.81
+4.79%
ABSI
Absci Corporation Co
2.74
-2.49%
What is CRL current stock price?
What are CRL stock strengths?
What is CRL Risk Level?
What is CRL market cap and volume?
What is CRL current Stock IQ?
Should I buy CRL stock right now?
Is CRL a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRL?
What does a 'Strong Sell' rating mean for CRL?
What factors influence CRL's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CRL
Charles River Labora
Current Price
$178.49
Runners Also Watch
IQV
IQVIA Holdings
178.81
+4.79%
ABSI
Absci Corporation Co
2.74
-2.49%

CRL Price Performance
$213.22 (-16.29%)
$187.12 (-4.61%)
$167.03 (+6.86%)
$174.98 (+2.01%)
CRL Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Revenue increase YoY
Loss widens YoY
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
CRL Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRL Street Sentiment is bullish and have positive views on the near-term outlook
CRL has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
CRL Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
CRL Latest Analysis
Harvards Massive Bet on Land Hits Harsh Real Estate Reality. A biotech downturn and pulled federal funds have stymied the universitys property bet in Bostons Allston neighborhood &mdash. while nearby MIT has thrived. Harvard had little room for growth in Cambridge its home since the 1600s. But just across the Charles River sat Allston a working-class Boston neighborhood where the university had assembled hundreds of acres of land. There Summers envisioned developing a sort of Silicon Valley of t
Wed Feb 25, 2026
Charles River Laboratories stock rises on divestiture plans.
Wed Feb 25, 2026
Baird Maintains Outperform Rating on Charles River Laboratories International Inc. (CRL). Charles River Laboratories International Inc. (NYSE:CRL) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 20 Mizuho Securities analyst Ann Hynes maintained her Neutral rating on Charles River Laboratories International Inc. (NYSE:CRL). She reduced the firms price target on the stock from $215 to $175. Estimates were [….]
Tue Feb 24, 2026
Charles River Laboratories International Inc. (NYSE:CRL) Q4 2025 Earnings Call Transcript. Charles River Laboratories International Inc. (NYSE:CRL) Q4 2025 Earnings Call Transcript February 18 2026 Charles River Laboratories International Inc. misses on earnings expectations. Reported EPS is $-5.61921 EPS expectations were $2.33. Operator: The Charles River Laboratories International Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. This call is being recorded. After the speakers&
Thu Feb 19, 2026
Charles River Laboratories beats top-line and bottom-line estimates. initiates FY26 outlook.
Wed Feb 18, 2026
Charles River projects up to 9% EPS growth in 2026 as new CEO acquisitions and cost savings drive margin expansion.
Wed Feb 18, 2026
Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates. Charles River (CRL) delivered earnings and revenue surprises of 2.51% and 0.84% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed Feb 18, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.